Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$8.8B
Revenue (FY25)
$4.0B
Rev. growth
-0.9%
Non-GAAP op margin
19.8%
Adj. EPS (FY25)
$10.28
GAAP net income
-$144M
Free cash flow
~$485M
P/E (fwd, adj.)
~17×
In plain English
Charles River is the picks-and-shovels company of drug discovery: it breeds the lab rats and mice researchers experiment on, runs the preclinical safety testing that every new drug must pass before human trials, and quality-tests and manufactures cell and gene therapies. Most of the world's approved drugs in the last few years passed through a Charles River lab — but the business is under pressure from a biotech funding slump and activist Elliott.
In simple terms
What Charles River Laboratories really sells
Charles River is the picks-and-shovels company of drug discovery: it breeds the lab rats and mice researchers experiment on, runs the preclinical safety testing that every new drug must pass before human trials, and quality-tests and manufactures cell and gene therapies. Most of the world's approved drugs in the last few years passed through a Charles River lab — but the business is under pressure from a biotech funding slump and activist Elliott.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.